These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 396479)

  • 1. Anti-tumor antibodies in lung cancer patients. Immunofluorescence study using various indicator cells.
    Górny MK; Jezewska E; Krzyśko R; Stawarz M; Zeromski J
    Neoplasma; 1979; 26(6):729-36. PubMed ID: 396479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
    Cronin WJ; Dorsett BH; Ioachim HL
    Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
    Paluch E; Ioachim HL
    J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL; Hammer C
    J Med; 1981; 12(6):447-53. PubMed ID: 7033427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
    Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
    Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-squamous tumor antibodies in patients with squamous cell carcinoma.
    Sofen H; O'Toole C
    Cancer Res; 1978 Jan; 38(1):199-203. PubMed ID: 338144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time lapse cinematographic demonstration of humoral and cell mediated immunity in squamous cell carcinoma of the lung.
    Vetterlein M; Auchmann M; Breit P; Cerni C; Micksche M; Wrba H
    Osterr Z Onkol; 1976; 3(4):99-102. PubMed ID: 1037019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
    Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
    Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
    Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-embryoglycan antibodies detected in sera of patients with uterine cervical cancer].
    Kato Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):129-35. PubMed ID: 1690252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.